These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26080061)

  • 1. A rapid, accurate and robust particle-based assay for the simultaneous screening of plasma samples for the presence of five different anti-cytokine autoantibodies.
    Guldager DKR; von Stemann JH; Larsen R; Bay JT; Galle PS; Svenson M; Ullum H; Hansen MB
    J Immunol Methods; 2015 Oct; 425():62-68. PubMed ID: 26080061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion-related inhibition of cytokines (TRICK). Experimental transfer of neutralizing autoantibodies to interleukin-6 by plasma transfusions.
    Hansen MB; Galle P; Salomo M; Svenson M; Dickmeiss E; Gimsing P
    Vox Sang; 2007 Apr; 92(3):213-23. PubMed ID: 17348870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.
    Wadhwa M; Meager A; Dilger P; Bird C; Dolman C; Das RG; Thorpe R
    Immunology; 2000 Jan; 99(1):113-23. PubMed ID: 10651949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
    Svenson M; Hansen MB; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
    Blood; 1998 Mar; 91(6):2054-61. PubMed ID: 9490690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study.
    von Stemann JH; Rigas AS; Thørner LW; Rasmussen DGK; Pedersen OB; Rostgaard K; Erikstrup C; Ullum H; Hansen MB
    PLoS One; 2017; 12(6):e0179981. PubMed ID: 28665954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors.
    Galle P; Svenson M; Bendtzen K; Hansen MB
    Eur J Immunol; 2004 Nov; 34(11):3267-75. PubMed ID: 15368270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Autoantibodies Are Associated with Infection Risk and Self-Perceived Health: Results from the Danish Blood Donor Study.
    von Stemann JH; Pedersen OB; Hjalgrim H; Erikstrup C; Ullum H; Thørner LW; Larsen MA; Burgdorf KS; Sørensen E; Hansen MB; Ostrowski SR
    J Clin Immunol; 2020 Feb; 40(2):367-377. PubMed ID: 31940126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of interleukin-6 (IL-6) autoantibodies on IL-6 binding to cellular receptors.
    Hansen MB; Svenson M; Abell K; Yasukawa K; Diamant M; Bendtzen K
    Eur J Immunol; 1995 Feb; 25(2):348-54. PubMed ID: 7875195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha.
    Svenson M; Hansen MB; Thomsen AR; Diamant M; Nansen A; Rieneck K; Otterness IG; Bendtzen K
    J Immunol Methods; 2000 Mar; 236(1-2):1-8. PubMed ID: 10699574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy.
    Ross C; Svenson M; Nielsen H; Lundsgaard C; Hansen MB; Bendtzen K
    Blood; 1997 Sep; 90(6):2376-80. PubMed ID: 9310488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
    Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
    Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors.
    Curry AE; Vogel I; Skogstrand K; Drews C; Schendel DE; Flanders WD; Hougaard DM; Thorsen P
    J Reprod Immunol; 2008 Apr; 77(2):152-60. PubMed ID: 17692390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Anticytokine Autoantibody Levels Are Not Increased in Hidradenitis Suppurativa: A Case-Control Pilot Study.
    Theut Riis P; von Stemann JH; Kjærsgaard Andersen R; Hansen MB; Jemec GBE
    Dermatology; 2017; 233(2-3):126-128. PubMed ID: 28675899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles.
    von Stemann JH; Gjærde LK; Haastrup EK; Minculescu L; Brooks PT; Sengeløv H; Hansen MB; Ostrowski SR
    Sci Rep; 2021 Dec; 11(1):23971. PubMed ID: 34907183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.
    Nagatomo Y; Li D; Kirsop J; Borowski A; Thakur A; Tang WH
    J Card Fail; 2016 Jun; 22(6):417-22. PubMed ID: 26997620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
    Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
    Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticytokine autoantibodies in chronic rhinosinusitis.
    Tsybikov NN; Egorova EV; Kuznik BI; Fefelova EV; Magen E
    Allergy Asthma Proc; 2015; 36(6):473-80. PubMed ID: 26534753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.